Society for Brain Mapping & Therapeutics Executive and Leadership Team

Patrick Shiong, the Chairman & Chief Executive Officer at Society for Brain Mapping & Therapeutics, directs the organization's overarching strategy and global vision. Shiong guides the society's mission to advance brain mapping, neurotechnology, and therapeutics, ensuring alignment with worldwide brain health transformation goals. This leadership involves fostering connections between clinicians, scientists, and innovators, a core tenet of the society's operational framework. Patrick Shiong oversees the strategic planning for major initiatives and events, including the annual Neurotech Congress, which serves as a critical platform for showcasing breakthroughs in neurosurgery and precision medicine. The Chairman & Chief Executive Officer champions policies that accelerate the translation of novel technologies into practical medical applications, directly impacting patient care and scientific progress. Shiong's executive oversight ensures the society's continued leadership in the field, driving forward advancements that benefit global neurological health.

Shiva Rampersad, the Chief Operating Officer at Society for Brain Mapping & Therapeutics, manages the day-to-day operations and execution of the organization's strategic objectives. Rampersad ensures the seamless functioning of all internal processes, supporting the society's global initiatives in brain mapping, neurotechnology, and therapeutics. This role involves optimizing resource allocation and operational efficiency to facilitate the connection between clinicians, scientists, and innovators. The Chief Operating Officer oversees the logistical and administrative aspects of key events, such as the annual Neurotech Congress, guaranteeing its successful delivery and impact. Shiva Rampersad is responsible for implementing policies that promote the rapid translation of new technologies into medical practice, working closely with leadership to streamline these efforts. Rampersad's operational management is crucial for advancing the society's mission to transform brain health worldwide.

Vicky Yamamoto, the President (2023-2024) at Society for Brain Mapping & Therapeutics, leads the organization's strategic direction and external relations during the specified term. Yamamoto focuses on advancing brain mapping, neurotechnology, and therapeutics, driving initiatives that connect clinicians, scientists, and innovators globally. This presidential role involves guiding the society's mission to transform brain health worldwide through collaborative efforts. Vicky Yamamoto oversees the planning and execution of major events, including the annual Neurotech Congress, ensuring its continued prominence as a showcase for neurosurgery and precision medicine breakthroughs. The President (2023-2024) advocates for policies that expedite the integration of new technologies into medical practice, fostering an environment conducive to rapid innovation. Yamamoto's leadership ensures the society's ongoing impact on global neurological advancements.

Warren Grundfest, the President at Society for Brain Mapping & Therapeutics, directs the organization's strategic initiatives and governance. Grundfest champions the advancement of brain mapping, neurotechnology, and therapeutics, fostering a collaborative ecosystem for clinicians, scientists, and innovators. This leadership role is pivotal in advancing the society's mission to transform brain health on a global scale. Warren Grundfest oversees the strategic development and execution of key programs, including the annual Neurotech Congress, a premier event for showcasing breakthroughs in neurosurgery and precision medicine. The President is instrumental in promoting policies that accelerate the translation of novel technologies into clinical practice, ensuring SBMT remains at the forefront of medical innovation. Grundfest's guidance solidifies the society's position as a leader in neurological health advancements.